Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?Natasja K van den Engel, Hauke Winter, Dominik Rüttinger, et al.
Journal of Translational Medicine|November 16, 2007
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesHauke Winter, Natasja K van den Engel, Dominik Rüttinger, et al.
Journal of Translational Medicine|September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discoveryDavide Bedognetti, James M Balwit, Ena Wang, et al.
Oncoimmunology|December 8, 2018
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumabGabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 27, 2015
Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastagingSimon Lavotshkin, John R Jalas, Hitoe Torisu-Itakura, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory responseFernanda I Arnaldez, Steven J O'Day, Charles G Drake, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cellsSybren L Meijer, Annemieke Dols, Walter J Urba, et al.
Journal of Thoracic Disease|January 21, 2012
Active-specific immunotherapy for non-small cell lung cancerHauke Winter, Natasja K van den Engel, Margareta Rusan, et al.
Head & Neck|October 23, 2020
Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection marginsLauren Hum, Daniel Bethmann, Zipei Feng, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodiesDavid Knorr, Rom Leidner, Shawn Jensen, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?Natasja K van den Engel, Hauke Winter, Dominik Rüttinger, et al.
Journal of Translational Medicine|November 16, 2007
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesHauke Winter, Natasja K van den Engel, Dominik Rüttinger, et al.
Journal of Translational Medicine|September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discoveryDavide Bedognetti, James M Balwit, Ena Wang, et al.
Oncoimmunology|December 8, 2018
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumabGabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 27, 2015
Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastagingSimon Lavotshkin, John R Jalas, Hitoe Torisu-Itakura, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory responseFernanda I Arnaldez, Steven J O'Day, Charles G Drake, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cellsSybren L Meijer, Annemieke Dols, Walter J Urba, et al.
Journal of Thoracic Disease|January 21, 2012
Active-specific immunotherapy for non-small cell lung cancerHauke Winter, Natasja K van den Engel, Margareta Rusan, et al.
Head & Neck|October 23, 2020
Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection marginsLauren Hum, Daniel Bethmann, Zipei Feng, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodiesDavid Knorr, Rom Leidner, Shawn Jensen, et al.
Pageof 16